hematologic malignancy

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

CB-Long-Term Safety Study (CB-LTSS)

Enrolling by invitation
  • Lymphoma, Non-Hodgkin
  • +7 more
  • Allogeneic CAR-T therapy
  • Irvine, California
  • +3 more
Nov 18, 2022

Diagnostic Performance of PointCheck in Pediatric Population

Recruiting
  • Hematologic Malignancy
  • PointCheck
  • Houston, Texas
    MD Anderson Cancer Center
Aug 16, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Thrombocytopenia, Hematologic Malignancy, Bone Marrow Aplasia Trial in Israel, Norway, United States (Thrombosomes, Liquid

Suspended
  • Thrombocytopenia
  • +5 more
  • Thrombosomes
  • Liquid Stored Platelets (LSP)
  • Duarte, California
  • +5 more
Apr 21, 2022

Hematologic Malignancy Trial in Italy, United States (Duvelisib)

Completed
  • Hematologic Malignancy
  • Denver, Colorado
  • +4 more
Mar 15, 2021

Hematologic Malignancy, Solid Tumor Trial in Houston (Voraxaze (Glucarpidase), Placebo)

Terminated
  • Hematologic Malignancy
  • Solid Tumor
  • Voraxaze (Glucarpidase)
  • Placebo
  • Houston, Texas
    U.T. M.D. Anderson Cancer Center
Dec 4, 2012

Fatigue in Emergency Center Patients

Terminated
  • Advanced Cancer
  • +2 more
  • Surveys
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Jul 26, 2012

Hematologic Malignancy Trial in Houston (drug, radiation, procedure)

Completed
  • Hematologic Malignancy
  • Houston, Texas
  • +1 more
Jun 27, 2012